Home > News > Nanoparticles May Detect Alzheimer's, Reversal Of Memory Loss
September 18th, 2003
Nanoparticles May Detect Alzheimer's, Reversal Of Memory Loss
Researchers have discovered for the first time in humans the presence of neurotoxic peptide assemblies that may be responsible for the memory loss found in individuals suffering from Alzheimer's disease (AD). The next step is to develop clinical diagnostics -- using nanoparticles -- to detect the amyloid beta-derived diffusible ligands (ADDLs), and effective drugs that prevent the onset of AD, delay its progression, and potentially restore cognitive function in patients with memory-related disorders, as reported in NanoBiotech News.
Malvern specialist to explore use of Nanoparticle Tracking Analysis for characterizing extracellular vesicles at ISEV 2014 March 11th, 2014
Arrowhead to Present at Barclays Global Healthcare Conference March 11th, 2014
Production of Bioactive Material for Quick Treatment of Bone Damages March 10th, 2014
Production of New Type of Electrochemical Drug Sensors for Cardiovascular Diseases March 10th, 2014